Journal
/
遗传学
/
A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
JoVE 杂志
遗传学
This content is Free Access.
JoVE 杂志 遗传学
A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

7,288 Views

•

10:07 min

•

August 25, 2017

DOI:

10.3791/56195-v

DOI:
10.3791/56195-v

•

10:07 min
August 25, 2017

•

2 Views
,
1Gene Editing Institute, Helen F. Graham Cancer Center and Research Institute,Christiana Care Health Services, 2Department of Medical Sciences,University of Delaware

Explore More Videos

CRISPR/Cas9SsODNOn-site MutagenesisHomology Directed RepairGene CorrectionHTT116 CellsTrypan BlueHemocytometerAphidicolinEGFP GeneGuide SequencesCrRNATracrRNA

Read Article

Cite this Article

Rivera-Torres, N., Kmiec, E. B. A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells. J. Vis. Exp. (126), e56195, doi:10.3791/56195 (2017).

Download .ris file

Copy

Share Video

.

Copy